Date
4 March 2025Location
Online via Webex, 13:00-14:00About the event
A facilitated case-based discussion about the complexities of polypharmacy and deprescribing. This was a follow on from our first webinar, which lays the foundations of some of the deprescribing tools available.
Why it’s important
The National Overprescribing review highlighted that 10% of medicines prescribed in primary care may be inappropriate and those taking 10 or more medicines are 300 times more likely to have a drug related hospital admission, highlighting the importance of deprescribing.
In England, 8.4m people are regularly prescribed 5 or more medicines, with 1 in 5 hospital admissions in over-65s caused by the adverse effects of medicines. 1 in 10 people over 65years take 8 or more medicines, rising to 1 in 4 in those over 85 years. Polypharmacy is associated with increased adverse drug outcomes, cost and medicines waste.
It is critical that clinician training or support to tackle overprescribing, encourages and facilitates shared decision-making, the importance of listening to patients, cultural competency, deprescribing, identifying adverse drug events and instances where harm outweighs benefits.
What was covered
- Case discussion about deprescribing for a patient with polypharmacy
- Insight into ‘a person-centred approach to deprescribing and optimising medicines outcomes for patients with problematic polypharmacy’
- Discussion about the challenges that professionals commonly encounter in relation to deprescribing
Speakers
Non-SPS speakers
Jasvir Singh Dhillon
Clinical Pharmacist (Shropshire, Telford & Wrekin ICB & GP practices)
SPS speakers
Learn more about the SPS team that are facilitating this event.
Resources
Information presented in these resources is correct at time of recording. Current guidance should be followed.
Webinar Recording
You can watch a recording of the webinar below.
Presentation resources
Slides from the presentation are now available below.
Contact us
Please contact the Admin Team if you have any questions.